Effect of Ketoconazole on the plasma pharmacokinetics of Axitinib (AG-013736) in healthy volunteers

被引：0
作者：
Pithavala, Yazdi
Klamerus, Karen
Garrett, May
Hee, Brian
Mount, Janessa
Selaru, Paulina
Sarapa, Nenad
机构：
[1] Pfizer Inc, San Diego, CA USA
[2] CPCS Pharma Consulting, Morristown, NJ USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
232
引用
收藏
页数：2
相关论文
共 50 条
[21]   Axitinib (AG-013736; AG) in patients (pts) with metastatic renal cell cancer (RCC) refractory to sorafenib [J].
Rini, B. I. ;
Wilding, G. T. ;
Hudes, G. ;
Stadler, W. M. ;
Kim, S. ;
Tarazi, J. C. ;
Bycott, P. W. ;
Liau, K. F. ;
Dutcher, J. P. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[22]   EFFECT OF KETOCONAZOLE AND RIFAMPICIN ON THE PHARMACOKINETICS OF MIRODENAFIL IN HEALTHY VOLUNTEERS [J].
Yi, S. J. ;
Kim, J. W. ;
Shin, H. S. ;
Yu, K. S. ;
Jang, I. J. ;
Shin, S. G. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 :S23-S23
[23]   Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer [J].
Jean-Philippe Spano ;
Malcolm J. Moore ;
Yazdi K. Pithavala ;
Alejandro D. Ricart ;
Sinil Kim ;
Olivier Rixe .
Investigational New Drugs, 2012, 30 :1531-1539
[24]   Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer [J].
Spano, Jean-Philippe ;
Moore, Malcolm J. ;
Pithavala, Yazdi K. ;
Ricart, Alejandro D. ;
Kim, Sinil ;
Rixe, Olivier .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) :1531-1539
[25]   Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers: A phase I study in Japanese patients [J].
Mukohara, Toru ;
Nakajima, Hikaru ;
Mukai, Hirofumi ;
Nagai, Shunji ;
Itoh, Kuniaki ;
Umeyama, Yoshiko ;
Hashimoto, Junichi ;
Minami, Hironobu .
CANCER SCIENCE, 2010, 101 (04) :963-968
[26]   AXITINIB (AG-013736; AG) IN COMBINATION WITH CHEMOTHERAPY (CT): A PHASE I STUDY IN PATIENTS (PTS) WITH GASTROINTESTINAL TUMOURS [J].
Robles, R. L. ;
Burgess, R. E. ;
Infante, J. R. ;
Tarazi, J. ;
Kim, S. ;
Tortorici, M. ;
Hee, B. ;
Sharma, S. .
ANNALS OF ONCOLOGY, 2008, 19 :157-157
[27]   Axitinib (AG-013736; AG) in combination with paclitaxel (P)/carboplatin (C) in patients (pts) with advanced solid tumors [J].
Cohen, Roger B. ;
Kozloff, Mark F. ;
Starr, Alexander ;
Pithavala, Yazdi ;
Tortorici, Michael ;
Liau, Katherine F. ;
Tarazi, Jamal ;
Olszanski, Anthony J. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3387S-3387S
[28]   Effect of food on the pharmacokinetics (PK) of axitinib in healthy volunteers (HVs) [J].
Tortorici, M. ;
Chen, Y. ;
Hee, B. ;
Ni, G. ;
Pithavala, Y. .
EJC SUPPLEMENTS, 2010, 8 (05) :71-71
[29]   Axitinib (AG-013736; AG) in patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sorafenib [J].
Rini, B. ;
Wilding, G. ;
Hudes, G. ;
Stadler, W. M. ;
Kim, S. ;
Tarazi, J. ;
Bycott, P. ;
Liau, K. ;
Dutcher, J. .
EJC SUPPLEMENTS, 2007, 5 (04) :300-300
[30]   A phase 2 study of axitinib (AG-013736), a potential inhibitor of VEGFRs, in patients with advanced thyroid cancer [J].
Cohen, R. ;
Vokes, E. E. ;
Rosen, L. ;
Kies, M. S. ;
Worden, F. P. ;
Kane, M. A. ;
Forastiere, A. A. ;
Liau, K. ;
Bycott, P. ;
Cohen, E. E. W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (02) :S136-S136
12345